Economic Challenges and Behavioral and Mental Health Risks for Overdose during the COVID-19 Pandemic among People Who Inject Drugs.
COVID-19
economic challenges
mental health
overdose risk
people who inject drugs
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
28 04 2022
28 04 2022
Historique:
received:
15
03
2022
revised:
21
04
2022
accepted:
26
04
2022
entrez:
14
5
2022
pubmed:
15
5
2022
medline:
20
5
2022
Statut:
epublish
Résumé
People who inject drugs (PWID) are a population that disproportionately struggles with economic and mental health challenges. However, despite numerous reports of people globally experiencing new or exacerbated economic and/or mental health challenges during the COVID-19 pandemic, the literature on the effect of the pandemic on PWID and their risk for harm (e.g., overdose) remains sparse. The present study will describe reported changes during the pandemic in risk factors for drug overdose (including changes in mental health symptoms and care access) among PWID in Chicago, and it will examine associations between such risk factor changes and the experience of economic challenges during the pandemic. Participants from an ongoing longitudinal study of young PWID from the Chicago suburbs and their injection risk network members (N = 138; mean age = 28.7 years) were interviewed about changes in their experiences, substance use behavior, and mental health since the start of the COVID-19 pandemic. Bivariate cross tabulations were computed of each "overdose risk factor" with experiences of economic challenges during the pandemic. Fisher's Exact Tests were used to assess statistical significance. Adjusted logistic regression models were also conducted that controlled for sociodemographic characteristics, for time elapsed since the start of the pandemic, and for pre-pandemic income, homelessness, and injection frequency. Over half of our sample reported using alone more than usual during the pandemic, and over 40% reported using more than usual and/or buying drugs that were of a decreased purity or quality. Additionally, a large proportion of our sample (52.5% of those asked) reported more difficulty than usual accessing mental health care. Experiencing loss of a source of income during the pandemic was associated with using more drugs, using alone more, using a larger amount of drugs while using alone, wanting to stop using but being unable, and difficulty accessing mental health care. The preliminary associations found by the present study suggest that economic challenges or disruptions experienced during the pandemic are likely to increase risk for overdose among PWID experiencing such challenges, via changes in the above behaviors and/or conditions that are associated with risk for overdose. Intervention efforts should therefore be focused not only directly on overdose prevention, but also on assisting PWID with their economic challenges and helping them regain economic stability and access to services that may have been impeded by financial difficulty.
Identifiants
pubmed: 35564746
pii: ijerph19095351
doi: 10.3390/ijerph19095351
pmc: PMC9101403
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIDA NIH HHS
ID : R01 DA043484
Pays : United States
Références
Public Health. 2021 Mar;192:8-11
pubmed: 33601307
Int J Drug Policy. 2020 Sep;83:102821
pubmed: 32591222
J Infect Dis. 2020 Sep 2;222(Suppl 5):S401-S409
pubmed: 32877554
J Addict Med. 2022 Mar-Apr 01;16(2):e133-e136
pubmed: 33840774
Front Psychiatry. 2020 Jul 21;11:714
pubmed: 32848907
J Urban Health. 2003 Jun;80(2):261-73
pubmed: 12791802
Int J Drug Policy. 2021 Apr;90:103082
pubmed: 33373906
J Acquir Immune Defic Syndr. 2021 Jan 1;86(1):19-21
pubmed: 33044323
Glob Health J. 2021 Mar;5(1):31-36
pubmed: 33614179
Epidemiology. 1990 Jan;1(1):43-6
pubmed: 2081237
Clin Infect Dis. 2021 Jun 1;72(11):e828-e834
pubmed: 33045723
Int J Drug Policy. 2020 Apr;78:102695
pubmed: 32143185
JAMA. 2020 Oct 27;324(16):1673-1674
pubmed: 32945832
Lancet Psychiatry. 2021 Jun;8(6):535-550
pubmed: 33639109
Harm Reduct J. 2021 May 10;18(1):52
pubmed: 33971892
Drug Alcohol Depend. 2020 Sep 1;214:108176
pubmed: 32717504
Epidemiology. 2020 Jul;31(4):551-558
pubmed: 32332222
Drug Alcohol Depend. 2021 Apr 1;221:108584
pubmed: 33607497
Psychol Med. 2021 Apr;51(6):881-893
pubmed: 33648613
J Community Health. 2021 Oct;46(5):960-966
pubmed: 33770334
Drug Alcohol Depend. 2012 Jul 1;124(1-2):70-8
pubmed: 22226707
J Int AIDS Soc. 2020 Jul;23(7):e25583
pubmed: 32697423